194 related articles for article (PubMed ID: 15168030)
21. Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.
Montenegro FL; Lourenço DM; Tavares MR; Arap SS; Nascimento CP; Massoni Neto LM; D'Alessandro A; Toledo RA; Coutinho FL; Brandão LG; de Britto e Silva Filho G; Cordeiro AC; Toledo SP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):131-9. PubMed ID: 22584718
[TBL] [Abstract][Full Text] [Related]
22. Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group.
Goudet P; Cougard P; Vergès B; Murat A; Carnaille B; Calender A; Faivre J; Proye C
World J Surg; 2001 Jul; 25(7):886-90. PubMed ID: 11572029
[TBL] [Abstract][Full Text] [Related]
23. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism.
Versnick M; Popadich A; Sidhu S; Sywak M; Robinson B; Delbridge L
Surgery; 2013 Jul; 154(1):101-5. PubMed ID: 23809488
[TBL] [Abstract][Full Text] [Related]
24. Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy.
Tonelli F; Giudici F; Cavalli T; Brandi ML
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):155-60. PubMed ID: 22584722
[TBL] [Abstract][Full Text] [Related]
25. Recurrent hyperparathyroidism and forearm parathyromatosis after total parathyroidectomy.
Melck AL; Carty SE; Seethala RR; Armstrong MJ; Stang MT; Ogilvie JB; Yip L
Surgery; 2010 Oct; 148(4):867-73; discussion 873-5. PubMed ID: 20800255
[TBL] [Abstract][Full Text] [Related]
26. Less than subtotal parathyroidectomy in multiple endocrine neoplasia type 1: A case report and review of the literature.
Kartini D; Dasawala F; Ham MF
Int J Surg Case Rep; 2020; 77():337-340. PubMed ID: 33212306
[TBL] [Abstract][Full Text] [Related]
27. Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1.
Salmeron MD; Gonzalez JM; Sancho Insenser J; Goday A; Perez NM; Zambudio AR; Paricio PP; Serra AS
World J Surg; 2010 Jun; 34(6):1325-31. PubMed ID: 20431882
[TBL] [Abstract][Full Text] [Related]
28. Surgical approach to the patient with familial hyperparathyroidism.
VanderWalde LH; Haigh PI
Curr Treat Options Oncol; 2006 Jul; 7(4):326-33. PubMed ID: 16916493
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment of primary hyperparathyroidism during MEN1 and other genetically determined forms].
Proye C
Ann Ital Chir; 2003; 74(4):417-22. PubMed ID: 14971285
[TBL] [Abstract][Full Text] [Related]
30. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Impact of genotype and surgical approach on long-term postoperative outcomes.
Shariq OA; Abrantes VB; Lu LY; Tebben PJ; Foster TM; Dy BM; Lyden ML; Young WF; McKenzie TJ
Surgery; 2024 Jan; 175(1):8-16. PubMed ID: 37891063
[TBL] [Abstract][Full Text] [Related]
31. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates.
Lee CH; Tseng LM; Chen JY; Hsiao HY; Yang AH
Ann Surg Oncol; 2006 Jan; 13(1):103-9. PubMed ID: 16378158
[TBL] [Abstract][Full Text] [Related]
32. Parathyroid surgery in familial hyperparathyroid disorders.
Carling T; Udelsman R
J Intern Med; 2005 Jan; 257(1):27-37. PubMed ID: 15606374
[TBL] [Abstract][Full Text] [Related]
33. Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
Bouriez D; Gronnier C; Haissaguerre M; Tabarin A; Najah H
World J Surg; 2022 Nov; 46(11):2666-2675. PubMed ID: 35767091
[TBL] [Abstract][Full Text] [Related]
34. Primary hyperparathyroidism in multiple endocrine neoplasia type 2A.
Raue F; Kraimps JL; Dralle H; Cougard P; Proye C; Frilling A; Limbert E; Llenas LF; Niederle B
J Intern Med; 1995 Oct; 238(4):369-73. PubMed ID: 7595174
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?
Fyrsten E; Norlén O; Hessman O; Stålberg P; Hellman P
World J Surg; 2016 Mar; 40(3):615-21. PubMed ID: 26541865
[TBL] [Abstract][Full Text] [Related]
36. Cystic parathyroid glands in MEN1: A rare entity?
Cavalli T; Giudici F; Nesi G; Amorosi A; Santi R; Brandi ML; Tonelli F
Fam Cancer; 2017 Apr; 16(2):249-256. PubMed ID: 27766445
[TBL] [Abstract][Full Text] [Related]
37. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient.
Thompson NW
J Intern Med; 1995 Sep; 238(3):269-80. PubMed ID: 7673858
[TBL] [Abstract][Full Text] [Related]
38. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Elaraj DM; Skarulis MC; Libutti SK; Norton JA; Bartlett DL; Pingpank JF; Gibril F; Weinstein LS; Jensen RT; Marx SJ; Alexander HR
Surgery; 2003 Dec; 134(6):858-64; discussion 864-5. PubMed ID: 14668715
[TBL] [Abstract][Full Text] [Related]
39. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
[TBL] [Abstract][Full Text] [Related]
40. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy.
Burgess JR; David R; Greenaway TM; Parameswaran V; Shepherd JJ
Arch Surg; 1999 Oct; 134(10):1119-23. PubMed ID: 10522858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
